Inventor · disambiguated record
Yuan Cheng
Also filed as: CHENG YUAN · CHENG YUAN BIN
30 granted patents·7 pending applications·147 citations·filing 2005–2025
96Inventor score
Top patents by PatentIndex Score
37 records- 0195US7652009B2Substituted heterocycles and methods of useAMGEN INC·Filed 2005·Granted Jan 26, 2010·33 cites·25 claims
- 0291US7880000B2Protein kinase modulators and method of useAMGEN INC·Filed 2005·Granted Feb 1, 2011·21 cites·19 claims
- 0391US7435823B2Compounds and methods of useAMGEN INC·Filed 2005·Granted Oct 14, 2008·19 cites·23 claims
- 0490US10905772B2Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR)AMGEN INC·Filed 2018·Granted Feb 2, 2021·6 cites·18 claims
- 0586US8476434B2Protein kinase modulators and method of useGEUNS-MEYER STEPHANIE D·Filed 2010·Granted Jul 2, 2013·17 cites·9 claims
- 0686US7872009B2Beta-Secretase modulators and methods of useAMGEN INC·Filed 2006·Granted Jan 18, 2011·11 cites·8 claims
- 0784US9296698B2Amino heteroaryl compounds as beta-secretase modulators and methods of useCHENG YUAN·Filed 2010·Granted Mar 29, 2016·5 cites·14 claims
- 0883US9895329B1Formyl peptide receptor 1 antagonists and uses thereofUNIV CHANG GUNG·Filed 2016·Granted Feb 20, 2018·3 cites·3 claims
- 0981US8921363B2Derivatives of 1 H-isoindol-3-amine, 1 H-iso-aza-indol-3amine, 3,4-dihydroisoquinolin-1-amine, and 1,4-dihydroisoquinolin-3-amine as beta-secretase inhibitorsMINATTI ANA ELENA·Filed 2011·Granted Dec 30, 2014·4 cites·7 claims
- 1080US9556135B2Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of useAMGEN INC·Filed 2013·Granted Jan 31, 2017·2 cites·38 claims
- 1180US9012446B2Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of useAMGEN INC·Filed 2013·Granted Apr 21, 2015·4 cites·20 claims
- 1280US2025121056A1Method of treating or ameliorating metabolic disorders using glp-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (gipr)AMGEN INC·Filed 2024·Application pending·0 cites
- 1378US8497264B2Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of useCHEN JIAN J·Filed 2011·Granted Jul 30, 2013·4 cites·29 claims
- 1477US7745484B2Beta-secretase modulators and methods of useAMGEN INC·Filed 2006·Granted Jun 29, 2010·2 cites·15 claims
- 1576US8883782B2Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of useCHENG YUAN·Filed 2011·Granted Nov 11, 2014·4 cites·18 claims
- 1673US9296759B2Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of useAMGEN INC·Filed 2012·Granted Mar 29, 2016·2 cites·11 claims
- 1773US9296734B2Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2014·Granted Mar 29, 2016·2 cites·39 claims
- 1872US7973047B2Beta-Secretase modulators and methods of useAMGEN INC·Filed 2010·Granted Jul 5, 2011·2 cites·21 claims
- 1971US9725469B2Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of useAMGEN INC·Filed 2013·Granted Aug 8, 2017·1 cites·15 claims
- 2070US9777019B2Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of useAMGEN INC·Filed 2016·Granted Oct 3, 2017·1 cites·13 claims
- 2170US7838676B2Beta-secretase modulators and methods of useAMGEN INC·Filed 2006·Granted Nov 23, 2010·1 cites·11 claims
- 2270US7626030B2Compounds and methods of useAMGEN INC·Filed 2005·Granted Dec 1, 2009·1 cites·25 claims
- 2369US12214051B2Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR)AMGEN INC·Filed 2021·Granted Feb 4, 2025·0 cites·14 claims
- 2469US9550762B2Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2015·Granted Jan 24, 2017·1 cites·95 claims
- 2567US11732266B2RNAi constructs for inhibiting ASGR1 expression and methods of use thereofAMGEN INC·Filed 2020·Granted Aug 22, 2023·0 cites·34 claims
- 2666US8178557B2Compounds and methods of usePOTASHMAN MICHELE·Filed 2008·Granted May 15, 2012·1 cites·21 claims
- 2761US2025074908A1Salt of rock inhibitor, crystal form of salt, composition, and pharmaceutical useWUHAN CREATERNA SCIENCE AND TECH CO LTD·Filed 2023·Application pending·0 cites
- 2858US2014107109A1Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of useAMGEN INC·Filed 2013·Application pending·0 cites
- 2956US8173810B2Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of useZHONG WENGE·Filed 2008·Granted May 8, 2012·0 cites·17 claims
- 3052US2023078200A1RNAi CONSTRUCTS AND METHODS FOR INHIBITING LPA EXPRESSIONAMGEN INC·Filed 2020·Application pending·0 cites
- 3151US2022049252A1CHEMICALLY-MODIFIED RNAi CONSTRUCTS AND USES THEREOFAMGEN INC·Filed 2019·Application pending·0 cites
- 3249US2025276080A1Glucagon receptor agonists and conjugates to glucose-dependent insulinotropic polypeptide antagonistsAMGEN INC·Filed 2025·Application pending·0 cites
- 3348US8338455B2Compounds and methods of useCHENG YUAN·Filed 2007·Granted Dec 25, 2012·0 cites·17 claims
- 3446US2017267673A1Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2016·Application pending·0 cites
- 3543US8163766B2Beta-secretase modulators and methods of useZHONG WENGE·Filed 2010·Granted Apr 24, 2012·0 cites·10 claims
- 3635US8735384B2Amino heteroaryl compounds as beta-secretase modulators and methods of usePARAS NICK A·Filed 2011·Granted May 27, 2014·0 cites·3 claims
- 3734US8822485B2Amino heteroaryl compounds as beta-secretase modulators and methods of usePARAS NICK A·Filed 2010·Granted Sep 2, 2014·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Yuan Cheng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →